Expertise

Scientific program leader

prof. dr. E. Hak is a SMBWO-acknowledged Senior Epidemiologist since 2001 and full professor of clinical pharmacoepidemiology at the Groningen Research Institute of Pharmacy since 2010.

Expertise at the University Groningen

Courses will be given by the unit PharmacoTherapy, -Epidemiology & -Economics (PTE2) which is part of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCEPP, see www.encepp.eu) and part of the SHARE graduate school. Elective courses and master projects can be followed at the units of PTE2 of the Pharmacy department as well as the Epidemiology and Clinical Pharmacy and Pharmacology departments of the University Medical Center Groningen. At these units, years of experience is available through research in the specific field of clinical epidemiology and pharmacoepidemiology.

Areas of expertise of the participating units:

Drug utilization and adherence (prof. dr. P. Denig, prof. dr. K. Taxis, prof. dr. E. Hak, dr. J. van Boven, Dr. Schuiling-Veninga);
Epidemiology of vaccine-preventable diseases (prof. dr. E. Hak);
Prognostic and diagnostic (oncological) epidemiological studies (prof. dr. E. Hak. prof. dr. G. de Bock);
Genetic pharmacoepidemiology (prof. dr. B. Wilffert);
Pharmacovigilance (prof. dr. K. Taxis. prof. dr. E. van Puijenbroek);
Statistical modeling, meta-analyses and mixed treatment comparisons (prof. dr. E. Hak);
Observational intervention studies (prof. dr. E. Hak, prof. dr. K. Taxis, Dr. Schuiling-Veninga);
Clinical trial methodology (prof. dr. E. Hak, prof. dr. B. Wilffert);
Pregnancy studies Dr. Schuiling-Veninga, prof. dr. E. Hak, prof. dr. B. Wilffert);
Evidence based medicine/pharmacology (all).

Recognizability of track and distinguishing features from other Epidemiology MScs

The Pharmacoepidemiology track focuses its contents on pharmaceutical research, notably pharmacovigilance, database research, observational and trial intervention methodology and utilization studies with specific attention to the role of pharmaceuticals in healthy ageing. This focus on pharmaceuticals is not part of other Epidemiology MScs such as the Top-master Clinical and Psychosocial Epidemiology of the UMCG or other Epidemiology master courses.

home-rechts-1

Niken

First year MPS student
Niken Widyakusuma

'I am a pharmacist and a teaching staff in the Faculty of Pharmacy, Universitas Gadjah Mada (UGM), Indonesia. I have worked in a pharmacy for a few months before I was involved in Management and Community Pharmacy Department in my university. I received my bachelor in pharmacy in 2010 and pharmacist in 2011, and I wanted to continue my education soon. I was looking for a master program in social pharmacy when I heard that RuG will open a Pharmacoepidemiology-Pharmacoeconomy track in MPS. I was suggested to take this track by a representative of RuG because RuG and UGM were developing cooperation by increasing staff mobility to each university.To me, pharmacoepidemiology offered comprehension on how to conduct a research in the society, and I was interested in comprehending the use of drugs in the society. Therefore, I chose this track.

So far, I found this program quite challenging because I am new to this field. It is surprising to reveal from the lectures, that many studies, even the internationally published papers, are mistaken. But, it is also interesting to work in a small group of classmates from different backgrounds and the friendly and helpful teachers.'

Expertise

Scientific program leader

Expertise at the University Groningen

Recognizability of track and distinguishing features from other Epidemiology MScs

First year MPS studentNiken Widyakusuma

First year MPS student
Niken Widyakusuma